Chinese ADRs and VIE-structure risk — what Indian investors must understand

For an Indian investor, the easiest-looking way into Chinese tech is also the most quietly dangerous. Alibaba, PDD (the Temu parent), JD.com, Baidu, NetEase — the household names of China's internet economy — all trade as American Depositary Receipts (ADRs) on US exchanges, buyable in dollars through any US brokerage account you already use for your S&P 500 ETFs. No Hong Kong account, no Stock Connect, no renminbi. It feels like buying Apple.

It is not like buying Apple. When you buy a typical Chinese ADR you are not buying shares in the Chinese operating business at all. You are buying a receipt over shares in a Cayman Islands shell company that holds nothing but a stack of contracts with the real, China-domiciled operating company — an arrangement called a Variable Interest Entity (VIE). Layered on top is a live US delisting threat that flared up again in 2025. This guide explains both risks plainly, because they are the two things that most distinguish a Chinese ADR from any ordinary US-listed stock — and the two things most retail buyers never hear about.

What an ADR is (the easy part)

An ADR is a US-traded certificate representing shares of a foreign company. A US bank (the depositary) holds the underlying foreign shares and issues dollar-denominated receipts that trade on NYSE or Nasdaq. For most countries this is genuinely just a convenience wrapper — a Toyota ADR represents real Toyota stock, an Infosys ADR represents real Infosys stock. You get the economics of the underlying company in a US-friendly form.

If Chinese ADRs were like that, there'd be little to write about. The complication is what sits underneath the Chinese ADR.

The VIE structure — what you actually own

China prohibits or restricts foreign ownership in many of its most valuable sectors — internet, media, education, telecoms. A foreigner (including a foreign-listed holding company) generally cannot directly own the licences and operating assets of a Chinese internet business. That is a hard legal wall.

So Chinese companies that wanted foreign capital engineered a way around it. The structure works like this:

1. The founders set up a shell holding company in the Cayman Islands (sometimes the British Virgin Islands).
2. That Cayman shell is what lists on the US exchange — the ADR represents shares in the shell.
3. The shell does not own the China operating company. Instead, it owns a wholly-foreign-owned enterprise (WFOE) inside China that signs a web of contracts with the real operating company: profit-transfer agreements, loan agreements, option agreements, and powers of attorney.
4. Those contracts are designed to pass the operating company's economics up to the shell — and therefore to you, the ADR holder — as if you owned it.

The operating company is the Variable Interest Entity. You, the foreign shareholder, have a contractual claim on its profits, not an equity claim on its assets.

Why this is the central risk

The entire edifice rests on contracts being enforceable. Three problems:

• The contracts are governed by Chinese law and enforced in Chinese courts. Chinese courts have, historically, given mixed signals about whether VIE contracts are even valid — they exist precisely to circumvent a foreign-ownership rule, which makes their legal standing inherently fragile.
• Beijing has tolerated, not blessed, the structure. For years the VIE was a regulatory grey zone. China has moved toward formal acknowledgement and oversight rather than a ban, but it has never granted the structure unambiguous, permanent legal security. A future tightening is always possible.
• If the contracts fail, you may own nothing of value. In a worst case, the Cayman shell's claim on the operating company evaporates and the ADR is left holding paper rights that a Chinese court won't enforce. This isn't a theoretical footnote — major Chinese ADR prospectuses spell out, in their own risk sections, that the VIE structure may not be enforceable and that investors could lose their entire investment.

The blunt summary: a Chinese ADR is a bet that the contracts hold and that Beijing keeps tolerating the workaround. That's a fundamentally different proposition from owning equity in a US, Japanese, or even Hong Kong-listed company.

The second risk — US delisting

Even if the VIE holds, there's a separate, geopolitical threat to where the ADR trades.

The HFCAA backstory

The Holding Foreign Companies Accountable Act (HFCAA), passed in 2020, requires that the US audit regulator (the PCAOB) be able to inspect the audit working papers of any company listed on a US exchange. China had historically blocked PCAOB access to mainland and Hong Kong audit firms on national-security grounds. Under the HFCAA as originally written, the SEC had to delist a company after three consecutive years of denied inspection — but a December 2022 amendment (the Accelerating HFCAA, folded into the year-end omnibus bill) shortened that to two consecutive years, so the trigger is now two years, not three.

In December 2022, after intense brinkmanship, China relented and the PCAOB announced it had — for the first time in history — secured complete access to inspect Chinese audit firms. That defused the immediate delisting countdown, and through 2023-24 the inspections continued. For a while, the issue went quiet.

Why it's live again in 2026

It came roaring back in 2025. In February 2025, the new US administration's "America First Investment Policy" memo signalled renewed scrutiny of US capital in Chinese companies, and members of Congress publicly pressed the SEC to revive HFCAA enforcement and consider forcing Chinese names off US exchanges. Through 2025, the delisting threat re-emerged as a genuine, market-moving risk rather than a settled matter — and it sits inside the broader US-China decoupling, which is political, not merely technical. As of early 2026 the inspection arrangement from 2022 still formally stands, but the political will to weaponise delisting has clearly returned, and the situation is fluid.

The practical takeaways for a holder:

• The threat is real but not imminent in a fixed-date sense — there's no automatic countdown ticking the way there was pre-2022. It's a policy risk that can escalate quickly if Washington chooses.
• A delisting is not necessarily a wipeout if the company has a Hong Kong listing — which is the single most important mitigant, and the reason it exists.

The Hong Kong secondary listing — your safety valve

Burned by the 2020-22 scare, almost every large Chinese ADR rushed to establish a secondary (or primary) listing in Hong Kong. This matters enormously to an Indian investor.

ADR (US)	Hong Kong listing	Notes
Alibaba (BABA)	9988.HK	Converted to primary dual-listing in HK
JD.com (JD)	9618.HK	HK-listed
Baidu (BIDU)	9888.HK	HK-listed
NetEase (NTES)	9999.HK	HK-listed
Trip.com (TCOM)	9961.HK	HK-listed
PDD Holdings (PDD)	No HK listing as of early 2026	Higher relative delisting exposure

The HK line is fungible-ish with the ADR for the big names — many brokers let you convert ADRs into the underlying Hong Kong shares, and if a US delisting ever forced the issue, holders of ADRs in dual-listed names would generally be able to move into the Hong Kong shares rather than being wiped out. The companies without a Hong Kong listing — PDD being the notable large example as of early 2026 — carry materially more delisting exposure, because there's no obvious place to land if the US door closes.

This single fact reshapes the Indian decision: if you want a Chinese internet name that has a Hong Kong listing, strongly consider buying the Hong Kong line directly rather than the US ADR. You get the same economic exposure, you sidestep the US delisting overhang entirely, and — as covered in the Hong Kong vs mainland gateway guide — Hong Kong levies no capital-gains tax and no dividend withholding at source. The ADR's only real advantage is that it sits in a US account you may already have.

The tax angle for an Indian holder

Chinese ADRs sit in a slightly awkward tax position, and it's worth being precise.

• The ADR trades in the US, so a naive reading says "US rules." But the underlying company is Chinese (technically Cayman-domiciled), so dividend treatment depends on where the dividend is sourced and how the depositary handles withholding. Chinese companies generally pay dividends with 10% Chinese withholding to non-residents; the depositary mechanics can complicate exactly what hits your account.
• In India, you are taxed on worldwide income regardless. Capital gains on the ADR are taxed in India by holding period, the same framework as any US stock — see how US stocks are taxed in India and model it with the capital-gains calculator.
• A genuine, easily-missed trap: holding a Chinese ADR is still holding a US-situs asset for US estate-tax purposes in many cases (ADRs are a grey area, but US-listed certificates can fall inside the net), which means the brutal $60,000 non-resident estate-tax exemption could apply — a problem we cover in depth for US holdings. Buying the Hong Kong line instead generally keeps you outside US estate tax altogether. That's a quiet but real second reason to prefer the HK listing for large positions.
• Schedule FA disclosure is mandatory on the ADR like any foreign asset — use the Schedule FA helper. If Chinese withholding does hit a dividend, claim the credit via Form 67 (renumbered Form 44 under the Income Tax Act 2025, effective for tax year 2026-27 returns — Form 67 still applies for returns filed in 2026 covering FY 2025-26; verify current) and the Form 67 / FTC calculator; the dividend-and-DTAA mechanics are detailed in China dividend tax and DTAA Form 67.

A short history of why investors should care

This isn't abstract risk theory — investors have already been burned, and the episodes are worth knowing because they show how each risk actually bites.

The VIE risk became real in 2021 when Beijing's regulatory crackdown on the education sector effectively destroyed the business models of US-listed Chinese tutoring companies almost overnight. Holders of those ADRs watched valuations collapse not because the companies failed commercially, but because a policy decision rendered their sector uninvestable — and the VIE structure meant foreign shareholders had no equity recourse to the underlying assets. The same crackdown era hit ride-hailing and internet names with data-security probes. The lesson: the VIE leaves you exposed to Chinese policy in a way direct equity in an open market does not.

The delisting risk became real in 2020-22, when the original HFCAA standoff sent Chinese ADRs into repeated sell-offs on every headline about audit access, before the December 2022 PCAOB agreement defused it. The market relief was visible and large — and so was the renewed anxiety in 2025 when the threat returned. Anyone who held through that period learned that a Chinese ADR's price can be driven as much by Washington-Beijing politics as by the company's earnings.

Both episodes share a theme: the extra risk in a Chinese ADR is non-fundamental. A great company can be hammered by structure and politics regardless of how well it executes. That's exactly why position sizing and the Hong Kong alternative matter so much.

ADR versus the Hong Kong line — a direct comparison

For a dual-listed name like Alibaba, here's the side-by-side an Indian investor should weigh:

	US ADR (e.g., BABA)	HK line (e.g., 9988.HK)
Currency	USD	HKD (pegged to USD)
What you own	Receipt over Cayman shell + VIE contracts	Listed shares (often primary in HK now)
US delisting (HFCAA) risk	Yes	No
Capital-gains tax at source	0% (US non-resident)	0% (HK has no CGT)
Dividend WHT	~10% Chinese, via depositary	0% at HK level (Chinese WHT may still apply on underlying)
US estate-tax exposure	Possible ($60k trap)	Generally none
Account needed	US brokerage (you may already have)	HK-capable broker (IBKR, Futu, etc.)
Convenience	Higher if you only have a US account	Slightly more setup

The ADR wins on one row — convenience — and loses or ties on every other. For any meaningful, long-held position, the Hong Kong line is structurally the better instrument. The route to buying it is in Hong Kong vs mainland, and the dedicated Hong Kong hub covers that market's brokers and tax treatment in full.

How to think about owning Chinese ADRs

None of this means Chinese ADRs are uninvestable. It means they carry two extra risk layers — VIE-structure legal risk and US delisting/geopolitical risk — that an Apple or Toyota ADR simply does not. Price those in.

A reasonable framework for an Indian investor:

1. Size it as a satellite, not a core holding. The combination of single-country, single-sector, structural, and political risk argues for a modest allocation, not a concentrated bet.
2. Prefer the Hong Kong listing where one exists. For Alibaba, JD, Baidu, NetEase and the rest, the HK line gives you the same business with less wrapper risk, no US delisting overhang, no source-country tax, and no US estate-tax exposure. The route is in how to buy via Hong Kong.
3. Treat names with no HK listing (e.g., PDD as of early 2026) as higher-risk, because they have no clear landing spot if delisting forces the issue.
4. Read the company's own risk section. Chinese ADR filings are unusually candid that the VIE may be unenforceable and that delisting is possible — they are telling you the truth in the fine print.
5. Remember the LRS and home compliance. You still funded this under the LRS, still pay TCS above Rs 10 lakh, and still owe Schedule FA. The exotic structure doesn't change the Indian plumbing.

The honest bottom line: a Chinese ADR is a leveraged bet not just on a company, but on a fragile legal structure and a volatile bilateral relationship surviving intact. If you understand that and still want the exposure, the Hong Kong listing is almost always the smarter way to take it. For the full set of routes into China, start at the China hub; to compare the gateways head to head, read Hong Kong vs mainland; and if you'd rather buy onshore champions with no offshore listing, see A-shares via Stock Connect.

---

This is general information, not investment, tax, or legal advice. VIE enforceability and US delisting policy are genuinely uncertain and politically driven; the position described reflects an understanding as of early 2026 and can change quickly. Company-specific structures and Hong Kong listing status vary — verify each name and consult a qualified cross-border advisor before investing.